DZ2479A1 - Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. - Google Patents

Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Info

Publication number
DZ2479A1
DZ2479A1 DZ980089A DZ980089A DZ2479A1 DZ 2479 A1 DZ2479 A1 DZ 2479A1 DZ 980089 A DZ980089 A DZ 980089A DZ 980089 A DZ980089 A DZ 980089A DZ 2479 A1 DZ2479 A1 DZ 2479A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
compositions containing
inhibitor compounds
inflammatory selective
inflammatory
Prior art date
Application number
DZ980089A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2479A1 publication Critical patent/DZ2479A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DZ980089A 1997-05-05 1998-03-02 Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. DZ2479A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
DZ2479A1 true DZ2479A1 (fr) 2003-02-01

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980089A DZ2479A1 (fr) 1997-05-05 1998-03-02 Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
WO2000024393A1 (fr) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
DE60023119T2 (de) * 1999-03-10 2006-07-20 G.D. Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
WO2001034204A1 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Produits composes oncolytiques destines au traitement du cancer
EP1283723A2 (fr) * 2000-05-15 2003-02-19 Merck Frosst Canada & Co. Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
PL206268B1 (pl) 2000-06-13 2010-07-30 Wyethwyeth Kompozycja przeciwbólowa i/lub przeciwzapalna oraz jej zastosowanie
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU8474701A (en) 2000-08-07 2002-02-18 Univ Vanderbilt Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
DK1534305T3 (da) 2003-05-07 2007-02-05 Osteologix As Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
WO2005009436A1 (fr) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Formulation dispersable d'un agent anti-inflammatoire
US20080269310A1 (en) * 2005-05-20 2008-10-30 Adrian Paul Foster Synergistic Combinations
ES2393814T3 (es) 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
ES2963291T3 (es) 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
EP2464341B1 (fr) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
KR102270323B1 (ko) * 2014-03-06 2021-06-29 아라타나 세라퓨틱스, 인크. 그라피프란트의 조성물 및 이를 사용하기 위한 방법
SG11201703553TA (en) 2014-11-07 2017-05-30 Sigmoid Pharma Ltd Compositions comprising cyclosporin
CN107106536A (zh) * 2015-01-09 2017-08-29 美洲豹动物健康公司 治疗伴侣动物的腹泻的方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
UY24989A1 (es) 2001-10-25
PL337003A1 (en) 2000-07-31
IL132570A0 (en) 2001-03-19
OA11213A (en) 2003-07-14
GT199800063A (es) 1999-10-26
NO995389L (no) 2000-01-04
PA8450601A1 (es) 2000-05-24
ZA983722B (en) 1999-11-04
AP9801234A0 (en) 1999-11-04
KR20040004406A (ko) 2004-01-13
EA003696B1 (ru) 2003-08-28
BR9808720A (pt) 2000-07-11
AR039628A2 (es) 2005-03-02
YU55899A (sh) 2003-08-29
EP0988034A1 (fr) 2000-03-29
AU6932198A (en) 1998-11-27
PE72599A1 (es) 1999-08-12
WO1998050033A1 (fr) 1998-11-12
AR011726A1 (es) 2000-08-30
HUP0001286A3 (en) 2000-12-28
ID21311A (id) 1999-05-20
NO995389D0 (no) 1999-11-04
BG103852A (en) 2000-06-30
JP2000513020A (ja) 2000-10-03
CA2288759A1 (fr) 1998-11-12
HRP980244A2 (en) 1999-02-28
HUP0001286A2 (hu) 2000-11-28
CN1255059A (zh) 2000-05-31
MA26491A1 (fr) 2004-12-20
EA199900895A1 (ru) 2000-06-26
KR20010012300A (ko) 2001-02-15
TW590773B (en) 2004-06-11
IS5220A (is) 1999-10-19
TNSN98059A1 (fr) 2005-03-15
SK148199A3 (en) 2001-09-11
NZ500183A (en) 2002-04-26

Similar Documents

Publication Publication Date Title
DZ2479A1 (fr) Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
DZ1916A1 (fr) Composés nouveaux et compostions pharmaceutiques les contenant.
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DZ2594A1 (fr) Dérivés de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
DZ2461A1 (fr) Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
DZ2361A1 (fr) Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
DZ2979A1 (fr) Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
CY2012029I1 (el) Νεα μορφη της s-ομεπραζολης
DZ2978A1 (fr) Composés chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
DZ2686A1 (fr) Formulation pharmaceutique orale à libération pulsée.
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
BR1100403A (pt) Composto e composição farmacêutica de inibidores de cox-2
NO980546D0 (no) Farmasöytiske midler
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
MA26492A1 (fr) Inhibiteurs de proteases nouveaux et compositions pharmaceutiques les contenant .
ATE268758T1 (de) Hypolipidämische propanolaminderivate
DZ2609A1 (fr) Composés nouveaux antagonistes des récepteurs de vitronectine et compositions pharmaceutiques les contenant.
IS5331A (is) Ný lyfjablanda
ID29294A (id) Komposisi farmasi